JP2015228829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015228829A5 JP2015228829A5 JP2014116753A JP2014116753A JP2015228829A5 JP 2015228829 A5 JP2015228829 A5 JP 2015228829A5 JP 2014116753 A JP2014116753 A JP 2014116753A JP 2014116753 A JP2014116753 A JP 2014116753A JP 2015228829 A5 JP2015228829 A5 JP 2015228829A5
- Authority
- JP
- Japan
- Prior art keywords
- expression level
- antibacterial
- peptide
- antimicrobial
- antibacterial agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 10
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 8
- 239000003242 anti bacterial agent Substances 0.000 claims 7
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 6
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 6
- 239000000186 progesterone Substances 0.000 claims 5
- 229960003387 progesterone Drugs 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 239000004599 antimicrobial Substances 0.000 claims 2
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 208000020154 Acnes Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 102100026887 Beta-defensin 103 Human genes 0.000 claims 1
- 241000186427 Cutibacterium acnes Species 0.000 claims 1
- 101000912247 Homo sapiens Beta-defensin 103 Proteins 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 229940055019 propionibacterium acne Drugs 0.000 claims 1
- 238000010187 selection method Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014116753A JP6371121B2 (ja) | 2014-06-05 | 2014-06-05 | 抗菌剤の選択方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014116753A JP6371121B2 (ja) | 2014-06-05 | 2014-06-05 | 抗菌剤の選択方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018132054A Division JP6611212B2 (ja) | 2018-07-12 | 2018-07-12 | ニキビ改善用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015228829A JP2015228829A (ja) | 2015-12-21 |
| JP2015228829A5 true JP2015228829A5 (https=) | 2017-05-18 |
| JP6371121B2 JP6371121B2 (ja) | 2018-08-08 |
Family
ID=54885984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014116753A Active JP6371121B2 (ja) | 2014-06-05 | 2014-06-05 | 抗菌剤の選択方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6371121B2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4141114A4 (en) * | 2020-04-24 | 2024-09-11 | Kao Corporation | METHODS FOR DETECTING THE SEVERITY OF PREMENSTRUAL SYNDROME |
-
2014
- 2014-06-05 JP JP2014116753A patent/JP6371121B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR21C1025I2 (fr) | Composition parasiticide comprenant un agent actif d'isoxazoline, son procede et utilisation | |
| NZ611606A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| PH12019550096A1 (en) | Beta-casein a2 and prevention of inflammation of the bowel | |
| Brabant et al. | Stimulant and motivational effects of alcohol: lessons from rodent and primate models | |
| EP3536253A3 (en) | Devices for removal of acute blockages from blood vessels | |
| BR112016029465A2 (pt) | chapa de aço elétrica | |
| BR112016019592A8 (pt) | Composto, uso de um composto, e, composição farmacêutica | |
| WO2016007629A3 (en) | Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations | |
| GB2556709A (en) | Product delivery control systems and methods | |
| CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
| SG10201808208PA (en) | Agent comprising imidazole dipeptide | |
| EP3630124A4 (en) | Synthetic composition comprising oligosaccharides and its use in medical treatment. | |
| IL269555A (en) | Glatiramer depot systems for treating progressive forms of multiple sclerosis | |
| MX2015015162A (es) | Agente de reduccion de acido urico. | |
| Dorin et al. | Mammalian antimicrobial peptides; defensins and cathelicidins | |
| JP2016509026A5 (https=) | ||
| FR3041536B1 (fr) | Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne. | |
| MX376087B (es) | Inhibidores macrocíclicos de cinasa rip2. | |
| JP2015228829A5 (https=) | ||
| MA42611A (fr) | Traitement combiné comprenant l'administration de 2-amino-3,5,5-trifluoro-3,4,5,6-tétrahydropyridines | |
| MX2017004649A (es) | Formulaciones nanoestructuradas para el suministro de silibinina y otros ingredientes activos para tratar enfermedades oculares. | |
| FR3012814B1 (fr) | Composition polymere comprenant et liberant un compose actif odorant | |
| BR112014017160A2 (pt) | sistema de administração de fragrância duradoura | |
| BR112017013154A2 (pt) | método para o monitoramento da evolução de um indicador usado para indicar o estado físico de um indivíduo, e dispositivo de monitoramento. | |
| Wei et al. | Dissemination of multidrug-resistant Campylobacter in wild birds from South Korea |